Drug interactions with smoking.

@article{Kroon2007DrugIW,
  title={Drug interactions with smoking.},
  author={Lisa A. Kroon},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  year={2007},
  volume={64 18},
  pages={
          1917-21
        }
}
  • Lisa A. Kroon
  • Published 2007
  • Medicine
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
    • PURPOSE The mechanisms for drug interactions with smoking and clinically significant pharmacokinetic and pharmacodynamic drug interactions with smoking are reviewed. SUMMARY Polycyclic aromatic hydrocarbons (PAHs) are some of the major lung carcinogens found in tobacco smoke. PAHs are potent inducers of the hepatic cytochrome P-450 (CYP) isoenzymes 1A1, 1A2, and, possibly, 2E1. After a person quits smoking, an important consideration is how quickly the induction of CYP1A2 dissipates. The… CONTINUE READING
    View PDF
    235 Citations
    11 Highly Influenced Papers
    78 Cite Background
    2 Cite Methods
    2 Cite Results

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 235 CITATIONS, ESTIMATED 51% COVERAGE

    [Smoking and drug interactions].

    Effects of Cigarette Smoking on Metabolism and Effectiveness of Systemic Therapy for Lung Cancer

    A review of smoking cessation: potentially risky effects on prescribed medications.

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    Influence of tobacco smoke exposure on pharmacokinetics of ethyl alcohol in alcohol preferring and non-preferring rats.

    Influence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane Therapy

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility.

    Considerations regarding drug interactions at smokers

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    Analysis of smoking behavior on the pharmacokinetics of antidepressants and antipsychotics: evidence for the role of alternative pathways apart from CYP1A2

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients.

    VIEW 3 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Influence of smoking on CYP2C19 genetic variants and clopidogrel efficacy in patients with minor stroke or transient ischaemic attack.

    FILTER CITATIONS BY YEAR

    2007
    2020

    CITATION STATISTICS

    • 11 Highly Influenced Citations

    • Averaged 11 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 33 REFERENCES

    Drug Interactions with Tobacco Smoking

    Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans.

    Metabolism and Disposition Kinetics of Nicotine

    Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.

    Role of the Smoking-Induced Cytochrome P450 (CYP)1A2 and Polymorphic CYP2D6 in Steady-State Concentration of Olanzapine

    Cigarette abstinence, nicotine gum, and theophylline disposition.

    Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age

    The role of nicotine in smoking-related cardiovascular disease.

    Effects of the CYP 2D6 Genotype and Cigarette Smoking on the Steady‐State Plasma Concentrations of Fluvoxamine and Its Major Metabolite Fluvoxamino Acid in Japanese Depressed Patients

    Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.